These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 1732381)

  • 21. Transforming growth factor-beta 1 localization in normal and psoriatic epidermal keratinocytes in situ.
    Kane CJ; Knapp AM; Mansbridge JN; Hanawalt PC
    J Cell Physiol; 1990 Jul; 144(1):144-50. PubMed ID: 1694857
    [TBL] [Abstract][Full Text] [Related]  

  • 22. IL-4 Downregulates IL-1β and IL-6 and Induces GATA3 in Psoriatic Epidermal Cells: Route of Action of a Th2 Cytokine.
    Onderdijk AJ; Baerveldt EM; Kurek D; Kant M; Florencia EF; Debets R; Prens EP
    J Immunol; 2015 Aug; 195(4):1744-52. PubMed ID: 26170379
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential expression of protein kinase C isoenzymes in normal and psoriatic adult human skin: reduced expression of protein kinase C-beta II in psoriasis.
    Fisher GJ; Tavakkol A; Leach K; Burns D; Basta P; Loomis C; Griffiths CE; Cooper KD; Reynolds NJ; Elder JT
    J Invest Dermatol; 1993 Oct; 101(4):553-9. PubMed ID: 8409523
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Keratinocytes derived from psoriatic plaques are resistant to apoptosis compared with normal skin.
    Wrone-Smith T; Mitra RS; Thompson CB; Jasty R; Castle VP; Nickoloff BJ
    Am J Pathol; 1997 Nov; 151(5):1321-9. PubMed ID: 9358758
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immune suppression by lysosomotropic amines and cyclosporine on T-cell responses to minor and major histocompatibility antigens: does synergy exist?
    Schultz KR; Bader S; Nelson D; Wang MD; HayGlass KT
    Transplantation; 1997 Oct; 64(7):1055-65. PubMed ID: 9381529
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Kinetics and regulation of human keratinocyte stem cell growth in short-term primary ex vivo culture. Cooperative growth factors from psoriatic lesional T lymphocytes stimulate proliferation among psoriatic uninvolved, but not normal, stem keratinocytes.
    Bata-Csorgo Z; Hammerberg C; Voorhees JJ; Cooper KD
    J Clin Invest; 1995 Jan; 95(1):317-27. PubMed ID: 7529261
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of PUVA, narrow-band UVB and cyclosporin on inflammatory cells of the psoriatic plaque.
    Erkin G; Uğur Y; Gürer CK; Aşan E; Korkusuz P; Sahin S; Kölemen F
    J Cutan Pathol; 2007 Mar; 34(3):213-9. PubMed ID: 17302604
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cell kinetic characterization of cultured human keratinocytes from normal and psoriatic individuals.
    van Ruissen F; de Jongh GJ; van Erp PE; Boezeman JB; Schalkwijk J
    J Cell Physiol; 1996 Sep; 168(3):684-94. PubMed ID: 8816923
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunologic aspects of acute cutaneous graft-versus-host disease: decreased density and antigen-presenting function of Ia+ Langerhans cells and absent antigen-presenting capacity of Ia+ keratinocytes.
    Breathnach SM; Shimada S; Kovac Z; Katz SI
    J Invest Dermatol; 1986 Mar; 86(3):226-34. PubMed ID: 2427602
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Overexpression of CD1d by keratinocytes in psoriasis and CD1d-dependent IFN-gamma production by NK-T cells.
    Bonish B; Jullien D; Dutronc Y; Huang BB; Modlin R; Spada FM; Porcelli SA; Nickoloff BJ
    J Immunol; 2000 Oct; 165(7):4076-85. PubMed ID: 11034419
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Overexpression of transforming growth factor alpha in psoriatic epidermis.
    Elder JT; Fisher GJ; Lindquist PB; Bennett GL; Pittelkow MR; Coffey RJ; Ellingsworth L; Derynck R; Voorhees JJ
    Science; 1989 Feb; 243(4892):811-4. PubMed ID: 2916128
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of heparin-binding EGF-like growth factor and amphiregulin in the epidermal proliferation of psoriasis in cooperation with TNFalpha.
    Yoshida A; Kanno H; Watabe D; Akasaka T; Sawai T
    Arch Dermatol Res; 2008 Jan; 300(1):37-45. PubMed ID: 17960400
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epidermal dendritic cells in psoriasis possess a phenotype associated with antigen presentation: in situ expression of beta 2-integrins.
    McGregor JM; Barker JN; Ross EL; MacDonald DM
    J Am Acad Dermatol; 1992 Sep; 27(3):383-8. PubMed ID: 1401271
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of dermal dendritic cells in psoriasis. Autostimulation of T lymphocytes and induction of Th1 type cytokines.
    Nestle FO; Turka LA; Nickoloff BJ
    J Clin Invest; 1994 Jul; 94(1):202-9. PubMed ID: 8040262
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased expression of CD208 (DC-LAMP) in epidermal keratinocytes of psoriatic lesions.
    Higaki M; Higaki Y; Kawashima M
    J Dermatol; 2009 Mar; 36(3):144-9. PubMed ID: 19335688
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Peptidoglycan and peptidoglycan-specific Th1 cells in psoriatic skin lesions.
    Baker BS; Laman JD; Powles A; van der Fits L; Voerman JS; Melief MJ; Fry L
    J Pathol; 2006 Jun; 209(2):174-81. PubMed ID: 16493599
    [TBL] [Abstract][Full Text] [Related]  

  • 37. T cell clones from psoriasis skin lesions can promote keratinocyte proliferation in vitro via secreted products.
    Prinz JC; Gross B; Vollmer S; Trommler P; Strobel I; Meurer M; Plewig G
    Eur J Immunol; 1994 Mar; 24(3):593-8. PubMed ID: 8125129
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transforming growth factor-beta receptor binding and function are decreased in psoriatic dermal endothelium.
    Cai JP; Falanga V; Taylor JR; Chin YH
    J Invest Dermatol; 1996 Feb; 106(2):225-31. PubMed ID: 8601720
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The mechanisms of action of cyclosporin A in the treatment of psoriasis.
    Wong RL; Winslow CM; Cooper KD
    Immunol Today; 1993 Feb; 14(2):69-74. PubMed ID: 8447934
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interleukin 1 alpha but not transforming growth factor beta inhibits tumor antigen presentation by epidermal antigen-presenting cells.
    Grabbe S; Bruvers S; Granstein RD
    J Invest Dermatol; 1994 Jan; 102(1):67-73. PubMed ID: 8288913
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.